Results 1 to 10 of about 1,594,274 (317)

Peroxisome Dysfunction and Steatotic Liver Disease. [PDF]

Int J Mol Sci
Vinoy N, Huang G, Wallace DF, Subramaniam VN.   +3 more
europepmc   +1 more source

Pharmacologic Confounders in Steatotic Liver Disease Outcomes Research-Reply. [PDF]

JAMA Intern Med
Ochoa-Allemant P, Hubbard RA, Serper M.
europepmc   +1 more source

Rare but relevant: Genetic liver disease in the general medical setting. [PDF]

Clin Med (Lond)
Allouni S, Ala A.
europepmc   +1 more source

Implementation of noninvasive liver disease screening tools in primary care. [PDF]

Korean J Fam Med
Nowak K, Nowak A, Jabłońska A, Potaczek A, Salacha J, Dardzińska N, Janczura J.   +6 more
europepmc   +1 more source

Prevalence and Impact of Chronic Liver Disease in Adult Patients Admitted With Cystic Fibrosis. [PDF]

Cureus
Yang Y, Li W, Jin C.
europepmc   +1 more source

Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023. [PDF]

J Viral Hepat
Kamal H, Jargalsaikhan G, Enkhtaivan S, Bruce D, Lindahl K, Dashtseren B, Ulziibadrakh T, Batkhuu M, Bat-Ulzii P, Byambabaatar S, Aleman S, Dashdorj NB.   +11 more
europepmc   +1 more source

The Gut-Liver Axis: Molecular Mechanisms and Therapeutic Targeting in Liver Disease. [PDF]

Int J Gen Med
Ma L, Wang H, Jin Q, Sun Z, Yu S, Zhang Y.   +5 more
europepmc   +1 more source

Cuproptosis as a Potential Therapeutic Target for Steatotic Liver Disease. [PDF]

Biomolecules
Pan Y, Luo C, Guo Q, Duan Q, Wu Z, Li Y.
europepmc   +1 more source